|
| Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Bullion ~ Forex ~ Sports ~ Technology ~ Health ~ Features |
| Lung Cancer ~ Lung Cancer ~ Breast Cancer ~ Heart attack ~ All Health Topics |
|
Home
/ Health News / 2008 / May 2008 / May 1, 2008 Scientists create heart, blood cells from reprogrammed mouse skin cells |
How binge drinking drives heart disease
Lack of exercise put depressed heart patients at greater risk
How cancer prevention drives aging
For the first time, researchers have found how cellular senescence, the well-known mechanism for preventing cancer, can trigger aging and age-related disease by changing the local tissue environment. ANI
Scientists unveil genes vital to vital to adult heart function
In a study on fruit fly Drosophila, scientists at the Burnham Institute for Medical Research (Burnham) have found that genes involved in embryonic heart development are vital to adult heart function in both fruit flies and humans. ANI
Psychiatric disorders common among college-aged
A new study has revealed that psychiatric disorders appear to be common among 18- to 24-year-olds, with overall rates similar among those attending or not attending college. ANI
Experts at the University of California, Los Angeles (UCLA) have successfully created functioning cardiac cells from mouse skin cells.
Washington, May 1 : Experts at the University of California, Los Angeles (UCLA) have successfully created functioning cardiac cells from mouse skin cells.
The researchers have revealed that they began their study by reprogramming mouse skin cells so that they would have the same unlimited properties as embryonic stem cells.
They claim that their research is the first to demonstrate that induced pluripotent stem cells (iPS) cells-which do not involve the use of embryos or eggs-can be differentiated into the three types of cardiovascular cells needed to repair the heart and blood vessels.
Dr. Robb MacLellan, senior author of the study, believes that this research may one day lead to clinical trials of new treatments for people who suffer heart attacks, have atherosclerosis, or are in heart failure.
Since the research team was also able to differentiate the iPS cells into several types of blood cells, adds MacLellan, there is a hope that this work may one day aid in treating blood diseases and in bone marrow transplantation.
"I believe iPS cells address many of the shortcomings of human embryonic stem cells and are the future of regenerative medicine," said MacLellan, an associate professor of cardiology and physiology.
"I'm hoping that these scientific findings are the first step towards one day developing new therapies that I can offer my patients. There are still many limitations with using iPS cells in clinical studies that we must overcome, but there are scientists in labs across the country working to address these issues right now," he added.
The study report, appearing in the online edition of the journal Stem Cells, also reveals that UCLA researchers are now trying to determine whether or not human iPS cells behave the same way as the mouse cells behave.
"Our hope is that, based on this work in mice, we can show that similar cardiovascular progenitor cells can be found in human iPS cells and, using a similar strategy, that we can isolate the progenitor cells and differentiate them into the cells types found in the human heart," MacLellan said.
ANI
